Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)

NCT04422652 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT04422652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04422652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
Lead sponsor
Stony Brook University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 24, 2020
Completion date
April 1, 2027
Enrollment
201 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, end stage kidney disease (esrd), major depressive disorder